<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
<% signal.analyst %>
Last Updated: Dec 24, 2025 10:11:58 AM (GMT)
HSIC: The current market price stands at $77.40, which represents a decline of 1% from the previous close.
Support and Resistance Levels The current support levels are $76.50, $76.00, and $75.50, while the resistance levels are $78.00, $78.50, and $79.00. The pivot point is at $77.00.
Indicators The RSI is at 24.39, indicating oversold conditions. ATR is declining, suggesting lower volatility at around 0.02. The ADX is high at 80.14, indicating a strong trend. The 50-day SMA is $77.40, close to the current price, while the 200-day EMA is also around $77.40. The Parabolic SAR shows support at $76.80.
Market Sentiment A bearish outlook is expected, as the current price is below the pivot point of $77.00 and the indicators suggest selling pressure.
HSIC Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (hsic) Henry Schein, Inc.
Company Background
Founded in 1932, Henry Schein, Inc. (NASDAQ: HSIC) is a leading global provider of healthcare products and services, with a strong focus on the dental, medical, and veterinary sectors. Headquartered in Melville, New York, Henry Schein operates in over 30 countries, serving more than one million customers worldwide. The company is dedicated to improving the performance of healthcare professionals by providing innovative solutions, efficient supply chain logistics, and cutting-edge technology enhancements.
Market Position
Henry Schein holds a prominent position in the healthcare market, ranking among the top distributors of healthcare products in the world. The company’s extensive product portfolio includes dental supplies, medical equipment, and pharmaceuticals, catering to a diverse range of healthcare providers. With a robust network of suppliers and a commitment to customer service, Henry Schein is well-positioned to meet the evolving needs of its clients while capitalizing on emerging market trends. The company's strategic focus on digital solutions and integrated services has allowed it to maintain a competitive edge in an ever-changing industry landscape.
Key Financial and Industry Highlights
In its recent financial report, Henry Schein demonstrated solid revenue growth, reflecting its resilience amid economic fluctuations. For the fiscal year ending 2022, the company reported revenues exceeding $3.5 billion, with an impressive year-over-year growth rate driven by increased demand for healthcare products and services. Henry Schein’s diversified market approach, coupled with its investment in digital transformation and telehealth solutions, positions the company for sustained growth in the coming years. Furthermore, the company’s commitment to corporate social responsibility and healthcare accessibility reinforces its reputation as a trusted partner in the healthcare industry.
As the healthcare landscape continues to evolve, Henry Schein remains at the forefront of innovation, dedicated to providing quality products and services that enhance patient care and improve practice efficiencies. With a strong financial outlook and a proactive approach to market challenges, Henry Schein, Inc. is poised for continued success in the global healthcare marketplace.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
